A new antiviral medication against respiratory syncytial virus, or RSV, appears to be safe and lowered viral levels and symptoms significantly more than a placebo, according to the results of a study published Wednesday in The New England Journal of Medicine.

(SOURCE) https://www.cnn.com/2022/02/17/health/rsv-potential-new-drug/index.html